Norwalk, Connecticut -- Second quarter sales at global chemical company Arch Chemicals were $443.8 million, up by only $2 million from the second quarter of 2010.
Income for the three months ended 30 June 2011 was $38 million, down from $43.5 million in the 2010.
In Arch's performance urethanes segment, Q2 sales were $52.5 million, up from $43.1 million in 2010. Operating loss for the quarter was $0.1 million in contrast to operating income of $0.4 million during Q2 2010.
The company said it is no longer providing its 2011 outlook. On 10 July, Arch Chemicals entered into an agreement to be acquired by Lonza Group Ltd, a transaction which remains pending.